General MedicationsORALGeneric
NEGGRAM
NALIDIXIC ACID
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NEGGRAM is listed in Drugs@FDA under application 014214 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NALIDIXIC ACID Form and strength TABLET;ORAL - 250MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2012-11-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEGGRAM is listed in Drugs@FDA under application 014214 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NALIDIXIC ACID Form and strength TABLET;ORAL - 250MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2012-11-28 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.